A hybrid fuzzy MCDM method for measuring the performance of publicly held pharmaceutical companies (Q2341238): Difference between revisions
From MaRDI portal
Latest revision as of 23:39, 9 July 2024
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A hybrid fuzzy MCDM method for measuring the performance of publicly held pharmaceutical companies |
scientific article |
Statements
A hybrid fuzzy MCDM method for measuring the performance of publicly held pharmaceutical companies (English)
0 references
23 April 2015
0 references
performance evaluation
0 references
balanced scorecard
0 references
DEMATEL
0 references
fuzzy ANP
0 references
fuzzy DEA
0 references
0 references
0 references